Seven Eight Capital’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-35,924
| Closed | -$699K | – | 955 |
|
2024
Q2 | $699K | Sell |
35,924
-63,954
| -64% | -$1.24M | 0.07% | 452 |
|
2024
Q1 | $3.75M | Buy |
+99,878
| New | +$3.75M | 0.39% | 66 |
|
2023
Q4 | – | Sell |
-10,161
| Closed | -$419K | – | 842 |
|
2023
Q3 | $419K | Buy |
+10,161
| New | +$419K | 0.05% | 429 |
|
2022
Q4 | – | Sell |
-19,061
| Closed | -$543K | – | 640 |
|
2022
Q3 | $543K | Buy |
+19,061
| New | +$543K | 0.11% | 261 |
|
2021
Q2 | – | Sell |
-1,500
| Closed | -$212K | – | 711 |
|
2021
Q1 | $212K | Hold |
1,500
| – | – | 0.05% | 368 |
|
2020
Q4 | $212K | Sell |
1,500
-1,700
| -53% | -$240K | 0.05% | 373 |
|
2020
Q3 | $399K | Buy |
+3,200
| New | +$399K | 0.09% | 399 |
|
2020
Q2 | – | Sell |
-5,500
| Closed | -$343K | – | 562 |
|
2020
Q1 | $343K | Buy |
+5,500
| New | +$343K | 0.09% | 285 |
|